SCHEMBL7503989

SCHEMBL7503989

CS(=O)(=O)c1ccc(-c2oc(Cc3ccccc3)nc2-c2c(Cl)cccc2Cl)cc1

nearest known ligand 0.49

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ PTGS2 P35354 14/20 0.49
▸ ALDH1A1 P00352 2/20 0.43
▸ MAPT P10636 2/20 0.43
▸ LMNA P02545 1/20 0.43
▸ PTGS1 P23219 4/20 0.42
▸ NR1H4 Q96RI1 1/20 0.41
▸ RXRA P19793 2/20 0.40
▸ RXRB P28702 1/20 0.40
▸ NR4A2 P43354 1/20 0.40
▸ JAK2 O60674 1/20 0.40
▸ JAK1 P23458 1/20 0.40
▸ TYK2 P29597 1/20 0.40
▸ JAK3 P52333 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7504508 0.94 PTGS2 (0.48) PTGS2ALDH1A1MAPTLMNAPTGS1
SCHEMBL7511138 0.91 PTGS2 (0.49) PTGS2ALDH1A1MAPTLMNAPTGS1
SCHEMBL7508771 0.91 PTGS2 (0.45) PTGS2ALDH1A1MAPTLMNAPTGS1
SCHEMBL7502817 0.89 CA1 (0.48) PTGS2ALDH1A1MAPTLMNAPTGS1
SCHEMBL7501104 0.88 RXRA (0.54) PTGS2ALDH1A1MAPTLMNAPTGS1
SCHEMBL7503014 0.87 PTGS2 (0.48) PTGS2ALDH1A1MAPTLMNAPTGS1
SCHEMBL7510702 0.87 PTGS2 (0.48) PTGS2ALDH1A1MAPTLMNAPTGS1
SCHEMBL7505514 0.87 RXRA (0.53) PTGS2ALDH1A1MAPTLMNAPTGS1
SCHEMBL7503836 0.87 PTGS2 (0.49) PTGS2PTGS1RXRAJAK2JAK1
SCHEMBL7511064 0.86 PTGS2 (0.57) PTGS2ALDH1A1MAPTLMNAPTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0699192-B1 SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2002-07-24 — — EP disclosed
US-6090834-A ANALGESICS; RHEUMATIC DISORDERS; SKIN DISORDERS; GASTROINTESTINAL DISORDERS G.D. SEARLE & CO. (US) 2000-07-18 — — US disclosed
EP-0825989-A1 SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1998-03-04 — — EP disclosed
US-5719163-A ARTHRITIS G.D. SEARLE & CO. (US) 1998-02-17 — — US disclosed
WO-1996036617-A1 SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-11-21 — — WO disclosed
EP-0699192-A1 SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-03-06 — — EP disclosed
WO-1994027980-A1 SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1994-12-08 — — WO disclosed
Send feedback